Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarker

por Oh, Esther S., Marano, Christopher M., Leoutsakos, Jeannie-Marie, Lee, Rebecca W., Rissman, Robert A., Smith, Gwenn S., Craft, Suzanne, Lyketsos, Constantine G.
Publicado 2015

Cloud-Based Brain Magnetic Resonance Image Segmentation and Parcellation System for Individualized Prediction of Cognitive Worsening

por Sakamoto, Ryo, Marano, Christopher, Miller, Michael I., Lyketsos, Constantine G., Li, Yue, Mori, Susumu, Oishi, Kenichi, ADNI, Alzheimer's Disease Neuroimaging Initiative
Publicado 2019

Clinical evaluation and management of a 45-year-old man with confusion, psychosis, agitation, stereotyped behavior, and impaired speech

por Deng, Xiaolin, Negro, Paulo J., Jung, Patrick L., Marano, Christopher M., Knight, Stephanie, Doddi, Seshagiri R., Nimo, Nana Y. A., LeMalefant, Rachel M., Myers, Drew A., Haake, Andrea K., Chandler, Rebecca
Publicado 2022

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

por Drye, Lea T., Spragg, David, Devanand, D. P., Frangakis, Constantine, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Pollock, Bruce G., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Publicado 2014